Status:
COMPLETED
Incidence Rate of Heart Failure After Acute Myocardial Infarction With Optimal Treatment
Lead Sponsor:
Harbin Medical University
Conditions:
Acute Myocardial Infarction
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
The main purpose of this study is to build a multi-center, prospective and regionally representative acute myocardial infarction(AMI) cohort，and build a study platform for heart failure caused by AMI;...
Detailed Description
the study aim to enroll 12000 acute myocardial infartion (AMI) patients, including ST-segment elevation myocardial infarction (STEMI) and non ST-segment elevation myocardial infarction (NSETMI), Patie...
Eligibility Criteria
Inclusion
- age≥18 years
- diagnosed acute myocardial infarction
- signed the informed consent form
Exclusion
- AMI is caused by surgery, trauma, gastrointestinal bleeding or complications of PCI;
- AMI occurred in patients who have been hospitalized for other reasons;
- patients with previous history of chronic heart failure;
- researchers judging that patient's compliance was poor and could not complete the study according to the requirements.
- life expectancy is less than 12 months;
- heart transplant patients;
- patients with tumors;
Key Trial Info
Start Date :
December 21 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
12043 Patients enrolled
Trial Details
Trial ID
NCT03297164
Start Date
December 21 2017
End Date
June 30 2021
Last Update
October 1 2021
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing An Zhen Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100029
2
Peking Univerisity People'Hospital
Beijing, Beijing Municipality, China, 100044
3
Beijing Chao-Yang Hospital, Capital Medical University
Beijing, Beijing Municipality, China
4
Peking University First Hospital
Beijing, Beijing Municipality, China